NEW YORK (GenomeWeb News) — Microchip Biotechnologies said today that it has licensed a patent and its related applications from the University of California, Berkeley.
According to MBI, the privately held firm has obtained an exclusive license for US Patent No. 6,623,613, "Microfabricated Liquid Sample Loading System" and related patent applications developed by UC Berkeley Professor Richard Mathies and his team.
Stevan Jovanovich, president and CEO of MBI, called the IP “foundational to MBI's ongoing development of a … nanofluidics platform for the construction of integrated devices."
Microchip Biotechnologies develops nanofluidic sample preparation and analytical instrumentation for the genomics and biodefense markets.
Last week, the company announced that it had raised $4.5 million in a Series A funding round.